Fundraising FoxVedanta Capital
Fund of fundsNew York · Growth · 10 people tracked
Find your way into Vedanta Capital
Each arrow is one introduction. Sign up to fill in the first one.
Ask Stefano Pacifico to introduce you to Alessandr Piol
You →Stefano · together at Epistemic →Alessandr
Ask Jamie Chen to introduce you to Jason Tronni
You →Jamie · together at Invesco →Jason
Ask Sam Okafor to introduce you to Shrikant Sathe
You →Sam · together at Vedanta Capital →Shrikant
- Parag Saxena5 people can intro you
- Howard Goldstein1 person can intro you
- Margaret Riley1 person can intro you
Sign up to find every way you can get introduced to Vedanta Capital
- Your email: who you already know at Vedanta Capital, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Vedanta Capital team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Vedanta Capital operates as an allocator offering limited partners access to venture capital and growth equity. Its funds of funds give institutions and individuals exposure to leading VC and growth equity funds, while its direct funds provide LPs direct access to venture- and growth-stage companies. The firm frames its mission around investing, empowering, and innovating.
Source: firm website, verified Aug 3, 2026.
Team · 10 people
from the firm's website & curated
What they invest in
from 22 of 49 portfolio companiesBiotech ×12Healthtech ×9Medical Devices ×7AI & Machine Learning ×5Digital Health ×5Consumer ×3Enterprise Software ×3Hardware ×3
HQs:United States×17India×2Ireland×1
Who they back
founder profiles across 14 portfolio companiesFounding team size:solo founder×122 founders×2
Investments · 49 tracked
founders shown can be your intro path
Alkermes develops pharmaceutical medicines for psychiatric and neurological disorders, including addiction, serious mental illness, and sleep disorders.
BiotechHealthtechMedical Devices
Richard F. Pops(Chairman of the Board, former CEO)Joshua Reed(Senior Vice President, Chief Financial Officer)inBlair C. Jackson(President & Chief Executive Officer)inDavid J. Gaffin(Executive Vice President, Chief Legal Officer and Chief Compliance Officer; Secretary)inCraig C. Hopkinson(Executive Vice President, Research and Development and Chief Medical Officer)C. Todd Nichols(Senior Vice President, Chief Commercial Officer)in
Co-investorsBain Capital Life SciencesCardinal PartnersHatteras Venture Partners
Bicara Therapeutics is a clinical-stage biopharmaceutical company developing bifunctional antibody therapies that combine tumor-targeting with immune-modulating payloads to treat solid tumors.
Ivan Hyep(Chief Financial Officer and Treasurer)inLara Meisner(Chief Legal Officer, Compliance Officer and Corporate Secretary)inDavid Raben(Chief Medical Officer)in
Co-investorsAisling CapitalEight Roads VenturesF-Prime CapitalForesite CapitalPremji InvestRA Capital+6 more
NW Bio develops personalized dendritic cell-based cancer vaccines intended to treat a range of solid tumor cancers as an alternative to chemotherapy.
BiotechHealthtechBethesda, US
Alton L. Boynton(Co-founder & Chief Scientific Officer)Marnix Bosch(Executive Officer)inLeslie Goldman(Executive Officer)Linda Powers(Executive Officer, Director)in
BoardNavid Malik(Director)Jerry Jasinowski(Director)
Co-investorsYorkville Advisors
Reviva Pharmaceuticals is a clinical-stage drug developer with a pipeline of two in-house-discovered new chemical entities, brilaroxazine (RP5063) and RP1208, developed using its chemical genomics platform.
BiotechDigital HealthHealthtechSanta Clara, US
Laxminarayan Bhat(Founder, President and Chief Executive Officer)Marc Cantillon(Executive Officer)inNarayan Prabhu(Executive Officer)inPurav Patel(Director)Les Funtleyder(Director)Richard Margolin(Director)
Revolutionizing space technology to make life multi-planetary
Hawthorne, US
Elon Musk(Founder, CEO & Chief Engineer)inBret Johnsen(Executive Officer)inGwynne Shotwell(Executive Officer, Director)
BoardAntonio Gracias(Director)inSteve Jurvetson(Director)inDonald Harrison(Director)
Co-investors1/1 Capital137 Ventures1802 Ventures2080 Ventures3Spoke Capital4DX Ventures+202 more
Axiado develops AI-driven, hardware-anchored platform security processors (its TCU chip) embedded in servers, 5G, network, and power management controller infrastructure.
CybersecurityHardwareSemiconductorsSan Jose, US
Ashok Babbar(Executive Officer, Director)Axel K. Kloth(Executive Officer, Director)
BoardDavid F. Welch(Director)
Co-investorsNosTerra Venture CapitalSamsung Catalyst FundCrosslink CapitalMaverick SiliconProsperity7 Ventures
Indian café chain operating in six countries
Co-investorsPeak XV Partners
Carbon Origins builds Bobby, an autonomous robot for hazardous work in construction, landscaping, and firefighting that combines AI autonomy with remote operator control via VR.
AI & Machine LearningConstruction TechGamingRoboticsLancaster, US
Amogha Srirangarajan(Founder)in
Co-investorsBread And Butter Ventures, LlcGROOVE CAPITALTechstarsBrickyard
Digi-Prex is a subscription pharmacy service that delivers medications to customers' homes monthly, offering prices up to 15% cheaper than traditional pharmacies.
B2B MarketplacesE-commerceHealthtechWellness & FitnessHyderabad, IN
Samarth Sindhi(Founder)in
Co-investorsGlobevestorITERATIVEOlive Tree CapitalPioneerSoma CapitalY Combinator+12 more
Epikast provides AI-powered tools for medical science liaisons and field teams to analyze clinical interactions with physicians and patients, and to access synthesized scientific information in their disease areas.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechSaaSBrooklyn, US
Evangelos Vergetis(Executive Officer, Director)
BoardOleg Nodelman(Director)inBrad Prosek(Director)Stelios Papadopoulos(Director)Daphne Karydas(Director)Alexandros Tzoukas(Director)
Co-investorsEcoR1 Capital
Genomic Health develops diagnostic tests and related services and runs health-equity initiatives aimed at improving access, awareness, and outcomes for patients and communities, including uninsured and underinsured populations.
BiotechDigital HealthHealthtechMedical Devices
Steve Shak(Founder)inKevin Conroy(CEO)in
Co-investorsKleiner PerkinsPfizer Venture Investments
Immuneel Therapeutics develops and manufactures cell-based immunotherapies, including CAR-T therapies, for cancer patients, with in-house cGMP lentiviral vector manufacturing.
BiotechHealthtechMedical Devices
Kiran Mazumdar-Shaw(Board Director & Co-founder)Siddhartha Mukherjee(Board Director & Co-founder)Amit Mookimin
Co-investorsF-Prime CapitalRainmatter
Jamba Juice is a food and beverage retail chain offering smoothies and blended beverages, including Over Ice drinks topped with Cloud Whip or Protein Cloud Whip.
ConsumerFoodTech
Co-investorsOak Investment Partners
Molecular Devices provides automated systems and services to support 3D cell biology research workflows, including cell culture automation, organoid expansion services, and imaging analysis tools for drug discovery and preclinical research.
AI & Machine LearningBiotechDeep TechEnterprise SoftwareHardwareMedical DevicesSan Francisco, US
Clinical-stage oncology company developing cancer treatments
BiotechDel Mar, US
Dana McGowan(Treasurer and Secretary)Karen Lundgren(Vice President and Chief Scientific Officer)Lauren G. Otsuki(Chief Business Officer)inJames Freddo(Chief Medical Officer)James B. Breitmeyer, M.D., Ph.D.(President and Chief Executive Officer)
BoardDavid F. Hale(Director)
Co-investorsMESA VERDE VENTURE PARTNERS
Parexel is a contract research organization (CRO) providing clinical development, regulatory consulting, and market access services for biopharmaceutical companies conducting clinical trials across phases I-IV globally.
BiotechDigital HealthHealthtechMedical DevicesBoston, US
Co-investorsCapvis AG
Global provider of standards-based unified communications solutions for voice, video, and content sharing.
Co-investorsAccelNorwest Venture PartnersOak Investment PartnersSirisVenrockPIPELINE CAPITAL PARTNERS
SetuServ operates a text analytics platform that combines AI/NLP with human analysts to analyze unstructured customer feedback from public and private channels, delivering insights via dashboards, APIs, and custom reports.
AI & Machine LearningData & InfrastructureSaaSChicago, US
ROSHAN ALVARES(Executive Officer, Director)SANGA REDDY PEERREDDY(Executive Officer, Director)
BoardPRABHAKANT SINHA(Executive Officer, Director)
Socrates Health Solutions is developing Companion, a non-invasive blood glucose monitor for people managing diabetes that avoids needles and finger pricks and provides real-time glucose readings, alerts, and historical tracking via mobile devices.
Digital HealthHardwareMedical DevicesDallas, US
Scott Smith(Founder & CEO)inSharon Gregory(Vice President of Operations)Peter(Chief Science Officer)
BoardHubert Zajicek(Director)inMichael Gorton(Board Member)Douglas Sutherland(Chairman of the Board)
Co-investorsHealth Wildcatters
Starbucks is a coffeehouse chain that sells espresso-based beverages, seasonal specialty drinks, and food items to consumers.
ConsumerFoodTechRetail TechSeattle, US
Howard Schultz(Founder)inBrian Niccolin
Co-investorsCapital Q® Ventures Inc.
TauC3 Biologics is a biotechnology company developing therapies for neurodegenerative diseases, with a focus on tau-related and Alzheimer's disease drug discovery.
BiotechDeep TechHealthtechLondon
Daniel G. Chain(President and Chief Executive Officer)inScott Pollack(Scientific/Platform Leader)inPeter McGowan(CFO)Shafique Virani(Director)John Gogol(Director)
BoardParag Saxena(Director)in
Ulta Beauty is an international specialty beauty retailer offering cosmetics, fragrance, skin care, wellness, hair care products, and salon services from over 600 brands across more than 1,500 locations primarily in the U.S., with additional operations in the U.K., Ireland, Mexico, and the Middle East.
ConsumerRetail TechWellness & FitnessBolingbrook, US
Dave KimbellinKecia Steelmanin
Co-investorsNorwest Venture PartnersOak Investment PartnersUpfront Ventures
A biopharmaceutical company developing medicines and vaccines with a focus on clinical research and development for human health.
BiotechSan Diego, US
David Johnson(Executive Officer, Director)Cam Gallagher(Director)Scott L. Glenn(Director)in
Co-investorsChiesi VenturesDecheng CapitalPappas CapitalSofinnova VenturesViking GlobalArix Bioscience+4 more
Verisign operates critical internet infrastructure, serving as the registry for the .com and .net top-level domains and as the Root Zone Maintainer for the global Domain Name System.
Cloud ComputingCybersecurityData & InfrastructureEnterprise Software
Jim Bidzos(CEO)in
Co-investorsBessemer Venture PartnersEverest GroupKleiner PerkinsMobility VenturesStoneMill VenturesWestern Technology Investment+1 more
Xaira develops AI and machine learning tools for drug discovery and protein design, serving pharmaceutical and biotech companies.
AI & Machine LearningBiotechMedical DevicesSouth San Francisco, US
Hetu Kamisetty(Founder)Marc Tessier-Lavigne(Chairman & Chief Executive Officer)inDr. Ci Chu(Chief Discovery Officer)Dr. Bo Wang(Chief AI Scientist)Dr. Ian McCaffery(SVP, Translational Science and Early Clinical Development)
Co-investorsARCH Venture PartnersBreyer CapitalDeviation CapitalF-Prime CapitalForesite CapitalLongwood Fund+4 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Amber NetworksAmbit Design SystemsAugereB-Portal BiologicsBreatheCelgeneCerespirCompUSACostcod2iDistilFLIPGADZooksKeyWLoan FrameMasimoOni SystemsPETSMARTSigmaTelStaplesTorrentVolterraWhite House Black Market
Exits · 5
5 IPOsAlkermesNASDAQ: ALKSBicara TherapeuticsNASDAQ: BCAXNorthwest BiotherapeuticsOTC: NWBOReviva PharmaceuticalsOTC: RVPHSpaceXNASDAQ: SPCX
Portfolio news
latest coverage across their companies
Alkermes · biospace.com · Jul 15, 2026
Ulta Salon Cosmetics Fragrance · finance.yahoo.com · Jun 24, 2026
Reviva Pharmaceuticals · revivapharma.com · Jun 23, 2026
Frequently asked questions
- How many investments has Vedanta Capital made?
- Vedanta Capital has 49 tracked investments, 5 of which have exited.
- What stage does Vedanta Capital invest at?
- Vedanta Capital invests at the Growth stage.
- What sectors does Vedanta Capital focus on?
- Vedanta Capital focuses on Sector Agnostic.
- Where is Vedanta Capital located?
- Vedanta Capital is headquartered in New York, US.
- Who does Vedanta Capital co-invest with?
- Vedanta Capital most often shares deals with Oak Investment Partners, F-Prime Capital, Accel, among 55 tracked co-investors.
Similar investors
New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.
Partech is a global venture capital firm supporting founders across multiple continents and investment stages through dedicated teams and funds.
Recharge Capital is a thematic-focused investment firm that invests across multiple asset classes in companies within its core themes, emphasizing a 'Thematic First' approach to identify high-potential opportunities in critical future industries.
Novastar Ventures is a venture capital firm backing entrepreneurs transforming markets and sectors across Africa, with a focus on positive impact for people and planet.